Literature DB >> 8128631

Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA.

M Moriuchi1, H Moriuchi, S E Straus, J I Cohen.   

Abstract

Varicella-zoster virus (VZV) open reading frame (ORF) 62 protein (the homolog of herpes simplex virus type 1 (HSV-1) ICP4) and ORF10 protein (the homolog of HSV-1 VP16) are virion-associated transactivators. To investigate whether these proteins function during the initial stages of VZV infection, human melanoma cells were cotransfected with purified VZV DNA, devoid of any structural proteins, along with a plasmid expressing VZV ORF62 or ORF10 under the control of the human cytomegalovirus major immediate-early promoter. Expression of ORF62 enhanced the infectivity of VZV DNA up to 70-fold. In contrast, expression of ORF10 enhanced the infectivity of VZV DNA only threefold. These results show that high-level expression of ORF62 protein increases the probability that transfected VZV DNA will result in productive infection, suggesting that this virion-associated transactivator (ORF62) has a critical role in initiating infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8128631     DOI: 10.1006/viro.1994.1190

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  42 in total

1.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein.

Authors:  Mohamed I Khalil; Ann Arvin; Jeremy Jones; William T Ruyechan
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo.

Authors:  Anne Schaap-Nutt; Marvin Sommer; Xibing Che; Leigh Zerboni; Ann M Arvin
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

4.  Probing of the nuclear import and export signals and subcellular transport mechanism of varicella-zoster virus tegument protein open reading frame 10.

Authors:  Mingsheng Cai; Shuai Wang; Jing Long; Chunfu Zheng
Journal:  Med Microbiol Immunol       Date:  2011-07-14       Impact factor: 3.402

5.  Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase.

Authors:  Amie J Eisfeld; Stephanie E Turse; Sara A Jackson; Edwina C Lerner; Paul R Kinchington
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro.

Authors:  J I Cohen; K Seidel
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Mutational analysis of varicella-zoster virus major immediate-early protein IE62.

Authors:  L Baudoux; P Defechereux; S Schoonbroodt; M P Merville; B Rentier; J Piette
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

8.  Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors.

Authors:  Mohamed I Khalil; Marvin Sommer; Ann Arvin; John Hay; William T Ruyechan
Journal:  Virology       Date:  2013-03-21       Impact factor: 3.616

9.  Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.

Authors:  Xibing Che; Leigh Zerboni; Marvin H Sommer; Ann M Arvin
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  Variability of immediate-early gene 62 in german varicella-zoster virus wild-type strains.

Authors:  A Sauerbrei; K Bohn; R Zell; P Wutzler
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.